|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pentachloronaphthalene | CAS 1321-64-8 | ||
| C10H3Cl5 | RTECS QK0300000 | ||
|
Synonyms & Trade Names Halowax® 1013; 1,2,3,4,5-Pentachloronaphthalene |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL: TWA 0.5 mg/m3 [skin] | ||
| OSHA PEL: TWA 0.5 mg/m3 [skin] | |||
| IDLH Unknown | Conversion | ||
|
Physical Description Pale-yellow or white solid or powder with an aromatic odor. |
|||
|
MW: 300.4 |
BP: 636°F |
MLT: 248°F |
Sol: Insoluble |
|
VP: <1 mmHg |
IP: ? |
|
Sp.Gr: 1.67 |
|
Fl.P: NA |
UEL: NA |
LEL: NA |
|
| Noncombustible Solid | |||
|
Incompatibilities & Reactivities Strong oxidizers |
|||
|
Measurement Methods NIOSH S96 (II-2) |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: Daily |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap promptly/molten flush immediately Breathing: Respiratory support Swallow: Medical Attention immediately |
|
Respirator Recommendations
NIOSH/OSHA Up to 5 mg/m3: (APF = 10) Any supplied-air respirator*/(APF = 50) Any self-contained breathing apparatus with a full facepiece Emergency or planned entry into unknown concentrations or IDLH conditions: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister having a high-efficiency particulate filter/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Headache, lassitude (weakness, exhaustion), dizziness, anorexia; pruritus, acne-form skin eruptions; jaundice, liver necrosis | |
|
Target Organs
Skin, liver, central nervous system |
|
| See also: INTRODUCTION |